MarketInOut Stock Screener Log In | Sign Up

HLB BioStep Co Ltd

KRX • Healthcare • Biotechnology • Quote as of 10/30/2026
HLB BioStep Co Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeKRX
Market Capitalization101,681 mln
Float14.00 mln

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.66
Likely reliable

Relative Strength

79 / 100
Strongly outperforming

Debt / Equity

0.33
Low leverage

Pre-Tax Margin

-23%
Deeply loss-making

ROE

-17.98
Negative

Business Description

Founded in 2012 and based in Incheon, South Korea, HLB bioStep is a contract research organization that supports the development of new drugs and treatments across a wide range of medical areas, including cancer, brain and bone diseases, liver conditions, respiratory illness, and skin disorders. The company provides non-clinical testing, veterinary drug development support, bioanalysis, and clinical trial services to help clients bring their products through the research and regulatory process. Previously operating under the name KNOTUS, the company serves as a broad testing and consulting partner for the life sciences industry in South Korea.

Key Fundamentals

EPS-1,084
ROE-17.98
RPS4,363
ROIC-4.63
ROA-11.80
EBITDA, mln-8,696
EV / EBITDA-6.42
EV / EBIT-3.99
Revenue, mln72,151
EV / Revenue0.77

Quote Details

Last 5,290.00
Change 40 (0.76%)
Open 5,250.00
Volume 639,886
Turnover 3,384,996,864
Average Volume 1,834,064

Financial Ratios

Pre-Tax Profit Margin-23
Current Ratio1.28
Price / Book0.58
Price / Tangible Book0.61
Debt / Equity0.33
Price / Sales0.77

Financial Strength

Altman Z-Score1.34
Piotroski F-Score 5 / 9
Beneish M-Score-2.66
Price to Intrinsic Value2.10

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -18.99% 2 / 100   
1 Month 53.78% 100 / 100   
2 Months 180% 100 / 100   
6 Months -11.17% 71 / 100   
1 Year -21.16% 41 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog